Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FH0J5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,419
Award facts
- Contract value 100% obligated
- $3,418.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,418.92 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on August 18, 2025, with an ultimate completion date of August 19, 2025. Dupixent (dupilumab) is a biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. The contract utilizes firm fixed pricing with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor. This delivery order represents a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain, delivering a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse medical procurement requirements across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle enables the company to supply pharmaceutical products to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, providing flexibility to meet evolving federal medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FH0J5?
SPE2DB25FH0J5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FH0J5 worth?
The government has obligated $3,419 on SPE2DB25FH0J5.
Is contract SPE2DB25FH0J5 an order under another contract?
Yes. SPE2DB25FH0J5 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH0J5 competed?
The extent of competition for SPE2DB25FH0J5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award